Rectal Cancer, Radiotherapy
6
2
3
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (6)
SCARLET - Italian proSpeCtionAl obseRvationaL multicEntre Study on Treatment for recTal pT1 Cancer
Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
Walking and Sitting Difficulties After Rectal Cancer Surgery
PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging
A Prospective Phase II Randomized Clinical Trial of Preoperative Chemotherapy Combined With Short-course Radiotherapy Versus Conventional Neo-adjuvant Therapy for Locally Advanced Rectal Cancer Implemented by MDT